LIST OF PUBLICATIONS

 

BOOKS

 

1.      Haynes C, Gillman MA (1992)

 

            Death the Last Great Adventure. Bizbee, U.S.A: Nomad Press.

 

2.       Gillman MA (1995)

 

          Stress - The change factor. Bizbee, U.S.A: Nomad Press.

 

3.    Gillman MA (1996)

 

          Envy as a retarding force in science. U.K. Aldershot: Avebury.

 

4.    Gillman MA (2004-2005)    

 

Psychotropic Analgesic Nitrous Oxide (PAN) Sedation 1st Edition – Textbook (in CD form).

 

5.    Gillman MA (2004-2007)

 

            Psychotropic Analgesic Nitrous Oxide (PAN) Sedation 2nd Edition – Textbook (in CD form).

 

6.     Gillman MA (2008)

 

            Psychotropic Analgesic Nitrous Oxide (PAN) Sedation 3rd Edition – Textbook (in CD form). Cerebrum Publishers, Johannesburg.

 

7.     Gillman MA (2010)

 

            Using Nitrous Oxide/Oxygen (PAN) sedation for treating nicotine dependence: A manual for Health Professionals. Cerebrum Publishers.

 

8.     Gillman MA

 

            Nitrous oxide and neurotransmission. New York: Novo Science (in press).

 

 

 

 

OTHER PUBLICATIONS  (Articles, Book Chapters & Letters to The Editor)

 

 

1.    Gillman MA, Lichtigfeld FJ (1980) Nitrous oxide: treatment of withdrawal symptoms.  Lancet 2: 803.

 

2.    Gillman MA, Kok L, Lichtigfeld FJ (1980) Paradoxical effect of naloxone on nitrous oxide analgesia in man. Eur J Pharmacol 61: 175-177.

 

3.    Gillman MA, Lichtigfeld FJ (1981) A comparison of the effect of morphine sulphate and nitrous oxide analgesia on chronic pain states in man. J Neurol Sci 45: 41-45

 

4.    Gillman MA, Lichtigfeld FJ (1981) The similarity of the action of nitrous oxide and morphine. Pain 10: 110

 

5.   Gillman MA, Kimmel I, Lichtigfeld FJ (1981) The dual system hypothesis of pain perception. Neurolog Res. 3 : 317-327

 

6.    Gillman MA, Footerman D (1981) The need for a clearer distinction between anesthesia and analgesia in relation to the opiate system.  Anesthesiology 54: 524

 

7.    Gillman MA, Lichtigfeld FJ (1981) Naloxone in Anorexia Nervosa - The role of the opiate system. J. Roy Soc Med 74: 631-632

 

8.    Gillman MA, Lichtigfeld FJ (1981) The almighty referee. New scientist 90: 644

 

9.    Gillman MA, Lichtigfeld FJ (1981) Management of alcohol withdrawal symptoms.

Brit Med J 203 : 64

 

10   Lichtigfeld FJ, Gillman MA (1982) The treatment of alcoholic withdrawal states with oxygen and nitrous oxide. S Afr Med J 61: 349-351

 

 

11.  Gillman MA, Lichtigfeld FJ (1981) The endorphins and stress.  S Afr Med J 61: 126

 

12.  Gillman MA, Lichtigfeld FJ (1981) The opiate system in traumatic brain death. Lancet 2: 156

 

13.  Gillman MA, Lichtigfeld (1981) Anorexia nervosa - A stress syndrome.  S Afr Med J 60: 376-377

 

14.  Gillman MA, Lichtigfeld FJ (1981) Naloxone and cerebral ischaemia. Lancet 2: 643

 

15.  Gillman MA, Lichtigfeld FJ (1981) Management of alcohol withdrawal symptoms.  Brit Med J 283: 674

 

16.  Gillman MA, Lichtigfeld FJ (1981) Cabal of referees. Nature 291: 608

 

17.  Gillman MA, Lichtigfeld FJ (1981) Solicited testimonials.  New scientist 91: 368

 

18.  Gillman MA, Footerman DS and Lichtigfeld FJ (1982) Nitrous oxide and anti-stress agent?  Anesthesiology 56: 234-235

 

19.  Gillman MA, Lichtigfeld FJ (1982) Possible drug differentiation of the psychoses. Am J Psychiatry 139: 384

 

20.  Gillman MA (1982) Nitrous oxide at analgesic concentrations an opiate agonist. Further evidence.  Anesth. Analg. 61: 394

 

21.  Gillman MA, Lichtigfeld FJ (1983) The effect of nitrous oxide and naloxone on orgasm in human females. A Preliminary report.  J.Sex Res 19: 49-57

 

22.  Gillman MA (1982) The principles of prescribing anti-microbial (anti-biotics)agents in dentistry.  J Dent Assoc S Afr 37: 191-192

 

23.  Gillman MA (1982) Anti-microbial agents used in dentistry - Part 1. J Dent Assoc S Afr 37: 9 657-658

 

24.  Gillman MA, Lichtigfeld FJ (1982) Oestrogen and parkinsonism. S Afr Med J 62: 46

 

25.  Gillman MA, Lichtigfeld FJ (1981) The possibility of an opiate and anti-opiate system.           J. Roy Soc Med. 74: 943

 

26.  Gillman MA, Lichtigfeld FJ (1983) Receptor hypothesis of the alcohol withdrawal state: CNS receptor- from molecular pharmacology to behaviour.  In: advances in biochemical psychopharmacology  V 37 Raven Press New York pp. 405-415

 

27. Gillman MA (1984) The possibility that nitrous oxide at analgesic concentrations is an opiate receptor agonist.  J. Soc Adv Anaesth Dent 5: 244-248

 

28.  Gillman MA, Lichtigfeld FJ (1983) Naloxone and its analeptic effect. Anesthesiology 58:287

 

29.  Gillman MA, Lichtigfeld FJ (1982) Dual system hypothesis of pain perception: Possible further evidence. Anesth Analg 61: 886-889

 

30.    Lichtigfeld FJ Gillman MA, (1983) The treatment of alcoholic withdrawal states with oxygen and nitrous oxide. S Afr Med J 63: 65-66

 

31.  Gillman MA, Lichtigfeld FJ (1982) Naloxone for alcohol intoxication.  Lancet 2: 558

 

32.  Gillman MA (1982) Possible dangers of naloxone use  J Am Med Assoc 248:2972-2973

 

33.  Gillman MA, Lichtigfeld FJ (1982) Intraspinal opiates and itching.  A New Reflex?

   Brit Med J 285: 1950

 

34.    Gillman MA (1982) Anti-microbial agent used in dentistry - Part 2. J Dent Assoc S Afr 37: 747-750

 

35.  Gillman MA, Lichtigfeld FJ (1982) Paradoxical effect of naloxone on nitrous oxide analgesia.  Brit J Anaesth 55: 91

 

36.  Gillman MA, Lichtigfeld FJ (1983) Nitrous oxide interacts with opioid receptors: More evidence.  Anesthesiology 58: 85-86

 

37.  Gillman MA (1982) Anti microbial agent used in dentistry - Part 3 Therapeutic notes. J Dent Assoc S Afr 38: 18-19

 

38.  Gillman (1982) The safety of nitrous oxide. Lancet 2: 1397

 

39.  Gillman MA, Lichtigfeld FJ (1983) The opiate system in Anorexia Nervosia Am J Psychiatry 140:371

 

40.  Gillman MA (1983) On peer review. S Afr Med J 63: 432

 

41.  Daras C, Cantrill RC and Gillman MA (1983) (3H)Naloxone displacement: evidence for nitrous oxide as opioid receptor agonist.  Eur J Pharmacol 89:177-178

 

42.  Gillman MA (1983) Antimicrobial aspects of treating osteomyelitis of the jaws and maxillo facial fractures.  J Dent Assoc S Afr 38: 493

 

43.  Gillman MA, Lichtigfeld FJ (1983) The opiate and anti-opiate system.  Evidence from involvement in withdrawal responses.  Can Anaesth Soc J 30:564-565

 

44.  Gillman MA, Lichtigfeld FJ (1983) The effect of naloxone on nitrous oxide analgesia.

  Pain 17: 103-104

 

45.  Lichtigfeld FJ, Gillman MA (1983) Treatment of alcoholic withdrawal state with oxygen and nitrous oxide.  Psychiat Digest (June) pp12-13

 

46.  Lichtigfeld FJ, Gillman MA (1982) Oxygen or laughing gas for alcohol withdrawal. Medicine Digest 8: 57

 

47.  Gillman MA, Sandyk R (1984) Parkinsonism induced by methyldopa.  S Afr Med J 65:194

 

48.  Gillman MA (1983) Pharmacology of analgesic agent used in Dentistry-Part 1.  J Dent Assoc S Afr 38:575-576

 

49.  Gillman MA (1983) Pharmacology of analgesic agent used in dentistry - Part 2.  J Dent Assoc S Afr 38: 697-698

 

50.  Gillman MA (1983) Antibiotic prophylaxis of infective endocarditis.  J Dent Assoc S Afr 38: 693

 

51.  Gillman MA, Sandyk R (1984) Tourette syndrome: Effect of analgesic concentrations of nitrous oxide and naloxone.  Brit Med J 288: 114

 

52.  Gillman MA, Sandyk R (1984) Haematuria following tricyclic therapy. Am J Psychiatry 141:463-464

 

53.  Gillman MA, Lichtigfeld FJ, (1983) The crisis-emergency pharmacotherapy.  S Afr Med J 65: 153-154

 

54.  Gillman MA, Lichtigfeld FJ (1984) An opioid involvement in Anorexia Nervosa - Further studies needed.  S Afr Med J 65: 4

 

55.  Sandyk R, Gillman MA (1983) Chronic bromocriptine therapy causes urinary incontinence.  Lancet 2: 1260-126

 

56.  Gillman MA, Sandyk R (1984) Bilateral internuclear ophthalmopogia reversed by naloxone.Arch Neurol 41:703

 

57.  Gillman MA, Lichtigfeld FJ, Sandyk R (1984) Subacute toxic delirium caused by nitrous oxide may be an acute withdrawal state.  Arch Neurol 41:704

 

58. Gillman MA, Sandyk R (1984) Nicotinic acid deficiency induced by sodium valproate.  S Afr Med J 65: 986

 

59. Gillman MA (1984) Naloxone and its antagonism of anesthesia and analgesia.  Can Anaesth Soc. J 31: 117-118

 

60. Sandyk R, Gillman MA (1986) The opioid system in the restless legs and nocturnal myoclonus Syndromes.  Sleep 9: 370-371

 

61.  Gillman MA, Sandyk R(1984) Hemifacial spasm - successful treatment with Baclofen.  S Afr Med J 65: 502

 

62. Gillman MA (1984) The hypertensive response to naloxone - A Commentary.  S Afr Med J 66: 551-552

 

63. Sandyk R, Gillman MA (1984) Motor dysfunction following chronic exposure to a flouroalkane solvent mixture containing nitromethane.  Eur Neurol 23: 479 - 480

 

64. Gillman MA (1984) Possible mechanisms of action of nitrous oxide at the opioid receptor.  Med Hypotheses 15: 109 - 114

 

65. Gillman MA, Sandyk R (1984) Nomifensine exacerbates depression and seizures in an epileptic patient. Neurology 34: 1620 - 1621

 

66. Sandyk R, Gillman MA (1985) Transient gilles de la Tourett Syndrome following alcohol withdrawal. Brit J Addiction 80: 213-214

 

67. Sandyk R, Gillman MA (1984) Naloxone of no benefit in levodopa-induced hallucinations in Parkinson's Disease.  Ann Neurol 16: 723

 

68. Sandyk R, Gillman MA (1984) Nor-adrenalin and tardive dyskinesia. Brit J Psychiatry 145: 217

 

69.  Sandyk R, Gillman MA (1984) Acute exacerbation of Parkinson's Disease with sulindac. Ann Neurol 17: 104-105

 

70.  Sandyk R, Gillman MA (1984) Blepharospasm associated with brainstem lesions. Neurology 34:1522-1423

 

71.  Gillman MA, Sandyk R (1985) Reversal of captopril-induced psychosis with naloxone.  Am J Psychiatry 142: 270,

 

72.  Sandyk R, Gillman MA (1984) Restless Leg Syndrome associated with amitriptyline.

Brit Med J 289: 162

 

73.  Lichtigfeld FJ, Gillman MA (1985) The therapeutic uses of opioid substances in psychiatry, with special reference to analgesic concentrations of nitrous oxide.  Update of psychiatric management, The Society of Psychiatrists SA ed. J.B. Carlile pp 76 - 79.

 

74.  Gillman MA  Nitrous oxide as an experimental investigative tool in medicine - An overview. in neuropsychology II, Proceedings of the 2nd S.A.  Neuropsychology Conference in Pretoria 1985 pp.63 - 66.

 

75.  Cantrill RC, Wallard DD, Daras C & Gillman MA Nitrous oxide: Its application in receptor binding studies  In Neuropsychology II, Proceedings of the 2nd S.A. Neuro­  psychology Conference in Pretoria 1985 pp. 73 - 82.

 

76.  Gillman MA, Lichtigfeld FJ (1984) The opioid and anti opioid system in addiction.    S Afr Med J 66:592

 

77.  Sandyk R, Gillman MA (1985) Nomifensine exacerbates oro-facial dyskinesia in hypothyroidism. neurology 35: 282 1985

 

78.  Sandyk R, Gillman MA (1985) Opioid hypofunction In Parkinson's Disease.  Med Hypotheses 16: 179-182

 

79.  Sandyk R, Gillman MA (1984) Colchicine ameliorates constipation in Parkinsonism. J Roy Soc Med 77: 1066

 

80.  Gillman MA, Sandyk R, Lichtigfeld FJ (1984) Evidence for underactivity of the opioid system in neuroleptic induced akathisia.  Psychiat Res 13: 187

 

81.  Sandyk R, Gillman MA (1987)  Baclofen in hemifacial spasm.  Int J Neurosci 33: 261-264

 

82.  Gillman MA,  Lichtigfeld FJ (1985) Nitrous oxide acts directly at Mu Opioid Receptors.  Anesthesiology 62: 375

 

83.  Gillman MA (1983) Adventure with nitrous oxide.  Proceedings of the Mine Medical Officer's Association of S.A. 62: 21

 

84.  Sandyk R, Gillman MA (1985) Nifedipine-induced psychosis. J Am Geriatric Soc 33: 154

 

85.  Sandyk R, Gillman MA (1985) Naloxone ameliorates narcolepsy.  Clin Neuropharmacol 8: 96-97

 

86.  Sandyk R, Gillman MA (1985) Nomifensine exacerbates narcolepsy.  Neurology 35: 138-139

 

87.  Gillman MA, Sandyk R (1985) Possible impact of weekly DST's on thyroid function in patients with affective disorders.  Am J Psychiatry 142: 662-663

 

88.  Gillman MA, Lichtigfeld FJ (1986)Minimal sedation required with nitrous oxide – oxygen treatment of the alcohol withdrawal state Brit J Psychiatry 148: 604-606

 

89.  Gillman MA, Sandyk R (1985) Opioid induced unconsciousness reversed by changes in opioid cholinergic and adrenergic function.  J Neurol, Neurosurg & Psychiat 48: 391

 

90.  Sandyk R, Gillman MA (1985) Nomifensine for emotional incontinence in the elderly. Clin Neuropharmacol 8: 377-378

 

91.  Gillman MA, Lichtigfeld FJ (1985) Nitrous oxide analgesia and the endogenous opioid system.  Can Anaesth Soc J 32: 200-201

 

92.  Gillman MA (1985) Cholecystokinin dopamine and the endogenous opioid system in

Schizophrenia. TIPS 6 (2): 64

 

93.  Sandyk R, Gillman MA (1985) Lithium induced visual hallucinations:  Evidence for possible opioid mediation.  Ann Neurol 17: 619-620

 

94.  Sandyk R, Gillman MA (1987) Phenelzine in migraine headaches.  Int J Neurosci 35: 243

 

95.  Sandyk R, Gillman MA (1986) Naloxone causes urinary urgency.  Urology 27: 79

 

96.  Sandyk R, Gillman MA (1985) Baclofen-induced memory impairment. Clin Neuropharmacol 8: 294-295

 

97.  Gillman MA, Sandyk R (1985) Auto-tolerance to the endogenous opioids and sleep. medical hypotheses 16: 393-395

 

98.  Sandyk R, Gillman MA (1985) Piracetam causes confusion in a patient with temporal lobe epilepsy.  J Amer Geriatric Soc 33: 305

 

99.  Gillman MA, Sandyk R (1985) Nitrous oxide ameliorates Spasmodic Torticollis.  Eur Neurol 24: 292 - 293

 

100.  Gillman MA, Lichtigfeld FJ (1984) Recovery after brain injury-some neurotransmitter and clinical implication.  Brit J Anaesth 56: 1319

 

101   Gillman MA (1985) Referees as arbiters of scientific contributions to the literature.               J Dent Assoc S. Afr 40: 140.

 

102.  Sandyk R, Gillman MA (1985) Depression as a cause of hallucinations in Parkinson's Disease. Clin Neuropharmacol 8: 199-200

 

103.  Gillman MA, Matussek N and Lichtigfeld FJ  Effect of Nitrous oxide on depressive patients and volunteers, In: Psychiatry: The State of the Art,Vol.2 pp. 397-404 (ed P Berner) Plenum Publishing New York 1985

 

104.  Gillman MA (1985) Anesthesia and analgesia are mediated by different mechanisms. Anesth and Analg 64: 752

 

105. Sandyk R, Gillman MA (1985) Maprotiline in nocturnal enuresis.  J Clin Psychiatry 46: 546

 

106.  Gillman MA, Lichtigfeld FJ (1985) High dose dihydrocodeine produces hyperalgesia.  J Roy Soc Med 78: 697-698

 

107.  Gillman MA, Sandyk R (1985) Response to opioids in 3 patients with restless leg syndrome. Am J Psychiatry 142: 662

 

108.  Gillman MA (1985) Naloxone and hypertension.  S Afr Med J 68: 73-74

 

109.  Gillman MA (1985) Nitrous oxide as an opioid and the association between the therapeutic use of narcotics and addiction.  Postgrad Med J 61: 653

 

110.  Gillman MA, Lichtigfeld FJ (1985) Analgesic nitrous oxide : Adjunct to clonidine for opioid withdrawal.  Am J Psychiatry 142: 784-785

 

111.  Sandyk R, Gillman MA (1985) Phenytoin toxicity induced by co-trimoxazole treatment.  Ann Int Med 102: 559

 

112. Gillman MA (1985) Nitrous oxide and its opioid emetic properties.  Canad Anaesth Soc J 32: 315

 

113.  Gillman MA,  Lichtigfeld FJ (1985) A pharmacological overview of opioid mechanisms mediating analgesia and hyperalgesia.  Neurological Res. 7:106-119

 

114.  Sandyk R,  Gillman MA (1985) Infantile autism: A dysfunction of the opioids? Med   Hypotheses 19: 41-45

 

115.  Gillman MA,  Sandyk R (1985) Tourette Syndrome and the opioid system. Psychiatry Res 15: 161-162

 

116.  Gillman MA,  Sandyk R (1986) Parkinsonism induced by a monoamine oxidase inhibitor.  Postgrad Med J 62: 235-236

 

117. Gillman MA (1986) "Nitrous oxide, an opioid addictive agent" Review of the evidence.  Am J Medicine 81: 92-102

 

118.  Sandyk ,R Gillman MA (1985) Cerebral glucose utilization in Parkinson's Diseases.             J Neurol Neurosurg Psychiatry 48: 489

 

119. Gillman MA,  Lichtigfeld FJ (1985) The endogenous opioid system and Anorexia Nervosa.  S.Afr. Med J 68: 454

 

120. Gillman MA (1986) Alcohol improves dystonia: opioid system involvement? Neurology 36: 303

 

121. Gillman MA,  Lichtigfeld FJ (1986) The opioids, dopamine cholecystokinin and eating disorders.  Clin Neuropharmacol 9: 91-97

 

122.  Lichtigfeld FJ  Gillman MA (1985) The use of sulphur hyperthermia in cancer. Eur J Surg Oncol 11: 299

 

123.  Gillman MA, Sandyk R (1985) Opiatergic and dopaminergic function and Lesch Nyhan Syndrome.  Am J Psychiatry 142: 1226

 

124.  Gillman MA (1985) Analgesic nitrous oxide: as an aphrodisiac.  Med Sex J S Afr 3:6

 

125.  Sandyk R, Gillman MA (1986) Tardive dyskinesia and glucose metabolism.

  Arch Gen Psychiat 43 : 192-3.

 

126.  Gillman MA, Lichtigfeld FJ (1985)  Lithium and Bulimia : The role of the dopaminergic and opiatergic system.  Am J. Psychiatry 142 :1522-3.

 

127. Gillman MA,  Lichtigfeld FJ (1986) Is nitrous oxide the primordial opioid substance? S. Afr. J Sci 82: 10

 

128.  Gillman MA,  Lichtigfeld FJ (1986) Naloxone morphine synergism :  Support for dual system  Hypothesis of pain perception.  Anesth Analg 65: 313

 

129.  Gillman MA (1986) Toxicity of bone marrow in dentists exposed to nitrous oxide.Br Med J 291: 1052

 

130.  Gillman MA, Lichtigfeld FJ (1986) Buprenorphine-naloxone synergism :  Evidence for dual system hypothesis of pain perception. anaesthesia 41: 211

 

131.  Gillman MA, Sandyk R (1986) The endogenous opioid system in Gilles De La Tourette Syndrome. Med Hypotheses 19: 371-378

 

132.  Gillman MA, Lichtigfeld FJ (1986) The paradox of naloxone. Brit J Anaesth 58: 572

 

133.  Gillman MA (1985) The use of nitrous oxide in investigating neurological disorders. Progress in Clinical Neuroscience Vol 2  Ed K.K. Sinha Neurological Society of India pp 87-90

 

134.  Gillman MA,  Lichtigfeld FJ (1985) Anaesthesia and alcohol.  Brit Med J. 291: 1505-1506

 

135. Sandyk R,  Gillman MA (1986) Amitriptyline for pain of cortical origin.  Clin Pharmac 5: 108

 

136. Gillman MA,  Lichtigfeld FJ (1986) Synergism by spironolactone and lithium in mania.  Brit Med J. 292: 661

 

137.  Gillman MA, Lichtigfeld FJ (1986) The opioids and the GABA-ergic differentiation of the psychoses.  S Afr Med J 69:163 - 164

 

138.  Gillman MA (1986) The safety of nitrous oxide.  J Am Dent Assoc 112: 12

 

139.  Gillman MA (1986) Pharmacokinetic differences could explain the lack of reversal of nitrous oxide analgesia by low dose naloxone.  Anesthesiology 65: 449

 

140.  Gillman MA, Lichtigfeld FJ (1986) Hyperalgesic opioid system.  S Afr J Sci 82: 402

 

141.  Sandyk R, Bamford C, Iacono RP, Gillman MA (1987) Cerebral cysticercosis presenting as progressive dementia.  Int J Neurosci 35: 251-254

 

142.  Sandyk R, Bamford CR, Gillman MA (1987) Clinical note : Opiates in the Restless Legs Syndrome. Int J Neurosci 36: 99-104

 

143.  Sandyk R, Bamford CR, Iacono RP, Consroe PF,  Gillman MA (1988) The electromyographic silent period is reduced in individuals at risk for Huntington's Disease.  Int J Neurosci 40: 109-110

 

144.  Sandyk R, Gillman MA, Iacono RP,  Bamford CR (1987) Clonidine in neuropsychiatric disorders:  A Review. Int J. Neurosci 35:205-215

 

145.  Gillman MA (1986) Analgesic (Sub Anesthetic) Nitrous oxide interacts with the endogenous opioid system: A review of the evidence. Life Sci. 39: 1209 - 1222

 

146.  Lichtigfeld FJ, Gillman MA, Sandyk R (1988) New vistas in chronic schizophrenia. Int J Neurosci 38: 355-367

 

147.  Gillman MA, Lichtigfeld FJ (1986) Analgesic actions of naloxone suggest the presence of an hyperalgesic opioid system.  S Afr Med J 70: 650-651

 

148.  Sandyk R,  Gillman MA (1987) Clonazepam-induced Tourette's Syndrome in a subject with hypereflexia.  Postgrad Med J 63: 311-312

 

149. Gillman MA 1987 Editorial - Haematological changes caused by nitrous: Cause for concern?  Brit J Aneasth 59: 143-147

 

150.  Gillman MA 1987 Substance abuse and the media.  S Afr Med J 71:418

 

151.  Gillman MA,  Lichtigfeld FJ (1987) Central beta-endorphin release by nitrous oxide.

J Oral Max-Fac Surg 45: 472, 515

 

152   Gillman MA, Lichtigfeld FJ (1987) Nitrous oxide analgesia is potentiated by low dose of naloxone :  More possible evidence of an hyperalgesic opioid system.      S Afr J Sci 83: 560-563

 

153.  Saffey K, Gillman MA, Cantrill R (1988) Chronic in vivo ethanol administration alters the sensitivity of adenylate cyclase coupling in homogenates of rat brain.  Neur Sci Let 84: 317-322

 

154.  Gillman MA (1988) Anti-neoplastic synergism of nitrous oxide and methotrexate.

Brit J Anaesth 60: 349-350

 

155.  Gillman MA, Katzeff IE (1988) Does opioid uncoupling of adrenal responses mediate opioid anti-stress effects?  Med Sci Res 16: 207 - 209

 

156.  Gillman MA, Katzeff IE, Vermaak WJH, Becker PJ,Susani E Hormonal responses to analgesic nitrous oxide in man. Horm Metab Res 20:751-754 (1988)

 

157.  Gillman MA (1988) Assessment of the effect of analgesic concentrations of nitrous oxide on human sexual response.  Int J Neurosci 43: 27-33

 

158.  Gillman MA, Lichtigfeld FJ (1988) Pellagra prevention project.  S Afr J Sci 84: 148-149

 

159.  Gillman MA (1988) Inhalation sedation with isoflurane: An alternative to nitrous oxide sedation in dentistry.  Brit Dent J 164: 204

 

160.  Gillman MA (1988) Folinic acid prevents megaloblastic changes associated with nitrous oxide.  Anesth Analg 67: 1018

 

161.  Gillman MA (1988) Smoking in airliners.  Lancet 1: 1054

 

162.  Dafny N, Gillman MA. Lichtigfeld FJ (1988) Cholecystokinin: induced suppression of feeding in fed, fasting and hypothalamic island rats.  Brain Res Bull 21: 225-31

 

163. Gillman MA (1988) Isoflurane :An appropriate alternative to analgesic nitrous oxide?

Br J Anaesth 61: 517-518

 

164. Gillman MA (1988) Analgesic nitrous oxide an unlikely trigger for malignant hyperthermia.  J Dent Assoc S Afr 43: 425

 

165.  Gillman MA (1988) The Data explosion.  Nature 333 : 698

 

166.  Gillman MA (1988) Analgesic nitrous oxide: Focus of the South African Brain Research Institute's Research. MRC News 19: 10-11

 

167.  Gillman MA, Lichtigfeld FJ (1988) Polydidpsia in psychosis  S Afr Med J 74: 536

 

168.  Gillman MA (1988) Orthodoxy and Homeopathy.  Nature 335: 292

 

169.  Gillman MA (1988) Disadvantages of air-oxygen mixtures replacing nitrous oxide. Anaesthesia 43: 898-899

 

170.  Lichtigfeld FJ, Gillman MA (1989) The effect of placebo in the alcohol withdrawal state.  Alc Alcohol 24: 109-112

 

171.  Gillman MA (1989) Analgesic nitrous oxide for addictive withdrawal states. S Afr Med J 75: 100-101

 

172.  Gillman MA. Shevel J Analgesic nitrous oxide and oxygen for acute withdrawal from cigarette smoking.  Proceeding of drug and alcohol research forum. Broederstroom; January 1988 pp. 66-74

 

173.  Gillman MA (1989) Replacing analgesic nitrous oxide with a dangerous alternative. Anesthesia 44: 255-256

 

174. Gillman MA (1989) Nitrous oxide and hypoxia : Is it the gas or the user?  Anaesthesia 44: 257

 

175.  Gillman MA (1989) Further evidence that analgesia and anesthesia are mediated by differing mechanisms.  Anesth Analg 68: 186

 

176.  Lichtigfeld FJ, Gillman MA (1990) Dangerous synergism between sedatives and a hyponatraemic state.  J Roy Soc Med 83: 185

 

177.  Gillman MA, Lichtigfeld FJ (1989) Analgesic nitrous oxide in neuropsychiatry: Past, present future.  Int J Neurosci 49: 75-81.

 

178.  Lichtigfeld FJ, Gillman MA (1989) Analgesic nitrous oxide for alcohol withdrawal is better than placebo.  Int J Neurosci 49: 71-74

 

179.  Gillman MA, Katzeff IE (1989) Anti-stress hormonal responses of analgesic nitrous oxide.  Int J Neurosci 49: 199-202

 

180. Gillman MA (1989) Physico-chemical basis of nitrous oxide activity at opioid receptors.      S Afr J Sci 85: 280-281

 

181. Gillman MA (1989) SABRI's Pellagra prevention project -  A year of Progress. S Afr J Sci 85: 214

 

182. Lichtigfeld FJ, Gillman MA (1989) Unique neurological signs in Wernicke's encephalopathy?  S Afr Med J 76: 517-518

 

183. Gillman MA, Lichtigfeld FJ (1989) Naloxone analgesia : update Int J Neurosci 48:321-324

 

184.  Gillman MA (1989) Different mechanisms may mediate anaesthesia and analgesia. Can J Anaesthesia 36: 734-735

 

185.  Lichtigfeld FJ, Gillman MA (1991) In spite of its validity has Dale's principle served its purpose? - A scientific paradox.  Perspect Biol Med 34: 239 - 253

 

186. Lichtigfeld FJ, Gillman MA (1990) Unique neurological signs in Wernicke's encephalopathy? (II)  S Afr Med J 77: 485-486

 

187. Gillman MA, Lichtigfeld FJ (1990) Analgesic nitrous oxide for alcohol withdrawal :            A critical appraisal after 10 years use.  Postgrad Med J 66: 543-546

 

188.  Lichtigfeld FJ, Gillman MA (1991) A fatal association between a seizure and drug induced Parkinsonism.  J Roy Soc Med 84: 237-238

 

189.  Gillman MA (1990) Opioid action of analgesic nitrous oxide. Ann Emerg Med 19:160/843-161/844

 

190.  Gillman MA (1990) Analgesic nitrous oxide as an investigative and therapeutic agent in psychiatry  Int J Neurosci 53:231-233

 

191.  Gillman MA, Lichtigfeld FJ (1990) Naloxone analgesia : Further developments  Int J Neurosci 52: 3-4

 

192. Gillman MA, Lichtigfeld FJ (1991) The opioid effects of analgesic (Subanesthetic) nitrous oxide on the alcohol withdrawal state.  Ann N Y Acad Sci 625: 784- 785

 

193.  Gillman MA,  Lichtigfeld FJ (1990) The drug management of severe alcohol withdrawal syndromes  Post Graduate Med J 66: 1005-1009

 

194.  Lichtigfeld FJ, Gillman MA (1990) Methylphenidate for reversal of drug-induced coma Clin Neuropharmacol 13: 459-460

 

195.  Gillman MA, Lichtigfeld FJ (1991) Is there a linkage between the action of nitrous oxide and melatonin?  Int J Neurosci 56: 207-208

 

196.  Gillman MA (1991) Are claims of false priority scientific misconduct or just evidence only of bad manners? S Afr J Sci 87:20 - 21

 

197  Lichtigfeld FJ, Gillman MA(1991)Combination therapy with carbamazepine/benz-odiazepine for polydrug analgesic/depressant withdrawal.  J Subst Abuse Treat 8: 293 - 295

 

198.  Gillman MA (1991) Dimethylthiourea not necessary to prevent the effect of nitrous oxide inactivation of methionine synthase  Brit J Anaesth 66: 274-275

 

199. Gillman MA (1991) Safety of nitrous oxide in association with sepsis.  S Afr Med J 79: 346

 

200.  Lichtigfeld FJ, Gillman MA (1991) Advances in understanding alcohol withdrawal states.  Post Graduate Med J 67: 700-701

 

201. Gillman MA, Lichtigfeld FJ (1991) Placebo and analgesic nitrous oxide for treatment of the alcohol withdrawal state.  Brit J Psychiatry 159: 672-675

 

202. Gillman MA 1991 Calcium hydroxide and sporadic clinical mycotoxicosis  J Nutr 7: 199-200

 

203. Gillman MA, Lichtigfeld FJ (1991) Impartiality of the South African Medical and Dental Council. S Afr Med J 80: 409

 

204. Gillman MA (1991) The Role of gases in neurotransmission  S Afr J Sci 87: 573

 

205. Gillman MA, Lichtigfeld FJ (1992) Neuroleptics in alcohol withdrawal  S Afr Med J 81: 45

 

206. Gillman MA, Lichtigfeld FJ (1992) Neuroleptics in alcohol withdrawal  S Afr Med J 81: 387

 

207. Gillman MA (1991) Sex and the ageing. Med Sex  J S Afr 2: 78

 

208. Lichtigfeld FJ, Gillman MA (1992) The opioid system and the placebo response Amer J Psychiatry 149: 276

 

209. Gillman MA, Lichtigfeld FJ (1992) Abuse of neuroleptic drugs?  Brit J Addiction 87: 937

 

210. Gillman MA (1992) One more cook stirring the maize pot.  J Nutr Health 8: 231

 

211. Gillman MA (1992) Drug education and the media. Nursing  RSA 7: 26-27

 

212. Gillman MA (1992) Nitrous oxide abuse in perspective Clin  Neuropharmacol 15: 297 - 306

 

213. Gillman MA, Is Premenstrual Syndrome a mini burn-out syndrome?  S Afr Med J 82: 285

 

214. Sandyk R, Kay SR, Gillman MA (1992) The role of melatonin in the antipsychotic and motor-side effects of neuroleptics: a hypothesis.  Int J Neurosci 64 : 203-207

 

215. Gillman MA (1992) Media statements by drug experts can be dangerous Nursing RSA 7:   19-20

 

216. Gillman MA (1993) Analgesic nitrous oxide should join the opioid family after almost two centuries.  S Afr J Sci 89: 25 - 27

 

217. Gillman MA (1992) Nitrous oxide as neurotransmitter. Lancet 339 : 307

 

218. Gillman MA, Lichtigfeld FJ (1993) Opioid/autonomic links in disease  J Rheumatol 20: 1083 -1084

 

219. Lichtigfeld FJ, Gillman MA (1994) Possible abuse of and dependence on major tranquilizers and tricyclic antidepressants.  S Afr Med J: 84:5-6

 

220. Gillman MA (1993) Nitrous oxide at homeopathic doses.  J Roy Soc Med 86 : 309 - 310

 

221. Gillman MA (1992) Nitrous oxide, Nitric oxide and neurotransmission. Brit Med J 305: 1368

 

222. Lichtigfeld FJ, Gillman MA (1992) Tranylcypromine abuse: cause for concern. Am J Psychiatry 149: 989

 

223. Lichtigfeld FJ,  Gillman MA (1994) Psychotropic analgesic nitrous oxide and neurotransmitter mechanisms involved in the alcohol withdrawal state.  Int J Neurosci 76: 17-33

 

224. Gillman MA, Lichtigfeld FJ (1994) Pharmacology of psychotropic analgesic nitrous oxide as a multipotent opioid agonist.  Int J Neurosci 76: 5-12

 

225. Ojutkangas R, Gillman MA (1994) Psychotropic analgesic nitrous Oxide for treating alcohol withdrawal in an outpatient setting.  Int J Neurosci 76: 35-39

 

226. Gillman MA (1994) Psychotropic analgesic nitrous oxide as an investigative, diagnostic and therapeutic tool.  Int J Neurosci 76: 1-3

 

227. Daynes G, Gillman MA (1994) Psychotropic analgesic nitrous oxide prevents craving after withdrawal from alcohol, cannabis and tobacco.  Int J Neurosci 76: 13-16

 

228. Gillman MA, Lichtigfeld FJ (1994) NO comments. Nature 367: 28

 

229. Gillman MA, Lichtigfeld FJ (1994) Opioid properties of psychotropic analgesic nitrous oxide (Laughing Gas).  Perspect Biol Med 38: 125-138

 

230. Gillman MA (1994) Analgesic nitrous oxide for addictive withdrawal. S Afr Med J 84: 516

 

231. Gillman MA, Lichtigfeld FJ (1995)  Opioid effects of psychotropic analgesic nitrous oxide on the dopaminergic system.  Anesth Analg 80: 855-6

 

232. Gillman MA (1995) Nitrous oxide has a very low abuse potential. Addiction 90: 439

 

233. Gillman MA (1994) Diagnosis and therapy with psychotropic analgesic nitrous oxide. The Leech 63: 51-54

 

234. Gillman MA, Lichtigfeld FJ (1994) The uses of analgesic nitrous oxide in neuropsychiatry.   S Afr Med J 84: 706

 

235. Lichtigfeld FJ, Gillman MA (1996) Role of dopamine mesolimbic system in opioid action of psychotropic analgesic nitrous oxide (PAN) in alcohol and drug withdrawal. Clin Neuropharmacol 19: 246-50

 

236. Gillman MA (1996) Alternative approach to the treatment of addictive withdrawal. S Afr J Sci 92: 184

 

237. Gillman MA, Lichtigfeld FJ (1995) Analgesic nitrous oxide effective for addictive withdrawal states? Psychiatry in Practice p16-17 Sept/October.

 

238. Gillman MA, Lichtigfeld FJ (1996) Effect of naloxone on nitrous oxide analgesia. Brit J Anaesth 77: 435-36

 

239. Gillman MA, Lichtigfeld FJ (1996) Pathophysiology of itching.  Lancet 348: 1513

 

240. Gillman MA, Lichtigfeld FJ (1997) Provisional registration of useful treatments. Lancet 349: 436-37.

 

241  Gillman MA (1997) Science and emotions Nature 386: 14.

 

242. Gillman MA, Lichtigfeld FJ (1997) The current status of analgesic nitrous oxide for treating alcoholic withdrawal states.  Finnish Med J (Suomen Laakarilehti) 52: 1055-58.

 

243. Gillman MA, Lichtigfeld FJ (1997) Industry and science.  Addiction 92: 1035

 

244. Gillman MA, Lichtigfeld FJ (1997) Provisional registration of useful treatments. Lancet 350: 737

 

245. Gillman MA, Shevel J (1997) Analgesic nitrous oxide and oxygen for acute withdrawal of cigarette smoking. Proceedings International Conference on Tobacco Smoking. Munich 461-463

 

246. Gillman MA, Lichtigfeld FJ (1998) Clinical role and mechanisms of action of analgesic nitrous oxide.  Int J Neurosci 93: 55-62.

 

247. Gillman MA, Lichtigfeld FJ (1998) A common pathway for addictions?  S Afr J Sci 94: 178.

 

248. Lichtigfeld FJ, Gillman MA (1998) Antidepressants are not drugs of abuse or dependence.  Postgrad Med J 74: 529-532.

 

249. Gillman MA, Lichtigfeld FJ (1998) Life-saving pills.  New Scientist 159:49.

 

250. Gillman MA, Lichtigfeld FJ (1998) Opioid properties of antidepresants  prevention & treatment 1: http://journals.apa.org/prevention/volume 1/com0010001a.html

 

251. Gillman MA (1999) Human passions and attribution in the history of science. Book Review. The birth of the Cell by H Harris. Lancet 353: 1533-34.

 

252. Lichtigfeld FJ, Gillman MA. (2000) Violence and the provision of community psychiatry. Lancet 355: 1804.

 

253. Gillman MA, Lichtigfeld FJ. (2000) Analgesic nitrous oxide: an opioid treatment for migraine Am J Emerg Med. 18: 501.

 

254. De Wet J, Lichtigfeld FJ, Gillman MA. (2001) Psychotropic analgesic nitrous oxide (PAN) for hyperactivity.  Aust New Zealand J Psychiat 35: 543-544

 

255. Lichtigfeld FJ, Gillman MA. (2001) Episodic dyscontrol: Relationship to Limbic Ictus and the underlying neurotransmitters  Brain Pharmacol 1, 59-72

 

256. Gillman MA (2001)Dark motives, Dark remedy. Book Review; Dark remedy. The impact of thalidomide and its revival as a vital medicine. by T Stephens, R. Brynner Lancet 357 : 1893.

 

257. Lichtigfeld FJ, Gillman MA. (2002). Possible role of the endogenous opioid system in the placebo response in depression.  Int J Neuropsychopharmacol 5: 107-8

 

258. Lichtigfeld FJ, Gillman MA. (2002). Role of the amygdala in addictive withdrawal Brain Pharmacol 1:189-196.

 

259. Gillman MA, Lichtigfeld FJ. (2002). Randomised double-blind trial of psychotropic analgesic nitrous oxide compared with diazepam for alcohol withdrawal state. J Subst Abuse Treat 22: 129-134.

 

260. Gillman MA (2002). Over cautiousness can be a disservice. S Afr Dent J 57:      298.

 

261.  Gillman MA (2002). No assumptions for safe nitrous oxide sedation. JADA  

         133: 1318,1320.

 

262.   Lichtigfeld FJ, Gillman MA. (2003). Another marker for depression. Int J    Neuropsychopharmacol 6: 91-2.

 

263.  Gillman, M.A., & Lichtigfeld, F.J. (2004) Enlarged double-blind randomised trial of benzodiazepines against psychotropic analgesic nitrous oxide for alcohol withdrawal Addictive Behaviors 29: 1183-1187.

 

264.  Gillman MA, Lichtigfeld FJ. (2004). Correct use of analgesic nitrous oxide for the alcohol withdrawal state essential. Clin Psychopharmacology 24: 238-239

 

265.  Gillman MA, Lichtigfeld FJ. (2004). Further comments on the effects of nitrous oxide treatment on alcohol withdrawal. J Clin Psychopharmacol 24:473-475.

 

266.  Gillman MA. (2004). Psychoneuroimunology is an offshoot of Selye’s pioneering work on stress. S Afr J Sci 99: 428.

 

267.  Gillman MA (2004). Conscious sedation. S Afr Dent J 59: 17.

 

268.  Gillman MA. (2004). Most effective method in routine conscious sedation for ambulatory patients. S Afr Dent J 59: 363-366.

 

269.   Gillman MA. (2004). Conscious sedation. S Afr Dent J 59: 17

 

270.   Gillman MA. (2004). Discovery of gasotransmission. The Scientist  18: 10

 

271.   Gillman MA & Lichtigfeld FJ (2004) An incorrect technique guarantees failure. Alc Clin Exp Res 28: 1273-1274.

 

272.   Gillman MA. (2004) Nitrous oxide sedation without adequate scavenging. (2004). S Afr Dent J 60: 68/77.

 

273.   Gillman MA, Lichtigfeld FJ, Young T. Psychotropic analgesic nitrous oxide for alcoholic withdrawal states. Cochrane Protocol  The Cochrane Library 2005, Issue 2.

 

274.   Gillman MA, Lichtigfeld FJ. (2006) Psychotropic analgesic nitrous oxide (PAN) as a probe of the endogenous opioid system in man and for treating substance abuse withdrawal  In: L.A. Bennet (Ed.), New Topics in Substance Abuse Treatment,  (pp. 1-72).New York: Nova  Science.

   

275.   Gillman MA. Introduction: In memoriam: FJ Lichtigfeld. Int J Neurosci 116: 827 - 833 .

 

276.   Gillman MA. (2005) Safety of using nitrous oxide for conscious sedation in asthmatic patients. S Afr Dent J 60: 347.

 

277.   Gillman MA. (2006) Psychotropic analgesic nitrous oxide for addictive withdrawal. Chinese J Drug Depend 14: 73-4.

 

278.   Gillman MA. (2006) It is illegal and unethical to use nitrous oxide/oxygen conscious sedation without scavenging   S Afr Dent J  61: 302 .

 

279.   Gillman MA, Lichtigfeld FJ, Harker N. (2006)  Psychotropic analgesic nitrous oxide for acute cocaine withdrawal in man. Int J Neurosci 116: 847-57.

 

280.   Gillman MA, Harker N, Lichtigfeld FJ. (2006)  Combined cannabis/methaqualone withdrawal treated with psychotropic analgesic nitrous oxide. Int J Neurosci 116: 859 - 869.

 

281.   Gillman MA, Lichtigfeld FJ. Nitrous oxide and carbon dioxide are both biologically and structurally similar. S Afr J Sci (in press).

 

282.   Gillman MA. (2006). Editorial: It is illegal and unethical to use nitrous oxide/oxygen conscious sedation without scavenging. S Afr Dent J 60: 382.

 

283.   Gillman MA. Safety of using nitrous oxide for conscious sedation in diabetic patients. S Afr Dent J 60: 347.

 

284.   Gillman MA, Lichtigfeld FJ, Young T. Psychotropic analgesic nitrous oxide for alcoholic withdrawal states. Cochrane Review. The Cochrane Library (in press).

 

285.   Gillman MA, Lichtigfeld FJ, Young T. (2007) Psychotropic analgesic nitrous oxide for alcoholic withdrawal states. (Review). The Cochrane Library, Issue 2.

 

286.   Gillman MA. (2007) Giving up smoking. Quest 4: 40.

 

287.   Gillman MA. (2008) Editorial: Tobacco cessation and nitrous oxide/oxygen sedation. SA DJ 63: 66.

 

288.   Gillman M.A. (2009). Psychotropic analgesic nitrous oxide [PAN] for substance abuse withdrawal In: Rees. J.P., Woodhouse, O. B. (Ed.), Substance withdrawal syndrome, (pp. 1-36). New York: Nova Science.

 

289.   Gillman MA. (2008) Psychotropic analgesic nitrous oxide (PAN) for alcohol withdrawal. Am J Health-Syst Pharm 65: 2205/2210.

 

290.   Gillman MA, Lichtigfeld FJ, Young T. (2008) Psychotropic analgesic nitrous oxide for alcoholic withdrawal states. (Review). The Cochrane Library, Issue 4.

 

291.   Gillman MA. (2009) Banning order by local journal. S Afr J Sci 104: 427.

 

292.   Gillman MA. (2011) Institutional action is unlikely to discourage plagiarism or other misconduct. Lancet (in press)